OMAR STEVE ZAPATA

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant BATON ROUGE, LA NPI 1821500596

General Payments — all program years on this page

$863.60

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $373.56 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $373.5618

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ITI, Inc. $109.945
Indivior Inc. $71.953
Lundbeck LLC $36.032
Supernus Pharmaceuticals, Inc. $35.782
Gilead Sciences, Inc. $34.141
ABBVIE INC. $33.022
Tris Pharma Inc $24.041
Vanda Pharmaceuticals Inc. $15.061
TOLMAR, INC. $13.601

By program year

Program yearAmountRecords
2022 $67.804
2023 $422.2424
2024 $373.5618

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1108457388 ABBVIE INC. $14.18 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108457390 ABBVIE INC. $18.84 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133719877 Gilead Sciences, Inc. $34.14 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133978286 Vanda Pharmaceuticals Inc. $15.06 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138716744 Tolmar, Inc. $13.60 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143633227 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.81 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143633229 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.40 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143633231 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.29 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143633233 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.92 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143633235 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.52 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144577166 Indivior Inc. $21.06 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144577168 Indivior Inc. $37.00 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144577170 Indivior Inc. $13.89 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146110710 Lundbeck LLC $15.63 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146110712 Lundbeck LLC $20.40 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147234003 Tris Pharma Inc $24.04 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147834112 Supernus Pharmaceuticals, Inc. $20.97 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147897994 Supernus Pharmaceuticals, Inc. $14.81 12/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.